Cite

HARVARD Citation

    Osterman, M. et al. (n.d.). P136 CERTOLIZUMAB PEGOL IS EFFECTIVE IN THE MAINTENANCE OF RESPONSE IN MODERATE-SEVERE ULCERATIVE COLITIS: AN OPEN-LABEL MAINTENANCE STUDY. Inflammatory bowel diseases. p. S49. [Online]. 
  
Back to record